By Dave Simpson ( February 11, 2022, 11:02 PM EST) -- The U.S. Food and Drug Administration will wait until Pfizer and BioNTech complete a clinical trial on the effectiveness of a three-dose COVID-19 vaccine for children between 6 months old and 4 years old before considering authorization of the first two doses for that age cohort, the agency said Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.